The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients

Clinical Neurophysiology

Volumn 111, Issue 8, 2000, Pages 1372-1379

  Orsnes G ^a   Crone, C ^a   Krarup, C ^a   Petersen, N ^b   Nielsen, J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Baclofen; Compound sensory action potentials; H reflex; Multiple sclerosis; Presynaptic inhibition; Spasticity

Indexed keywords

BACLOFEN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONDITIONED REFLEX; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HOFFMANN REFLEX; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE POTENTIAL; NEUROTRANSMITTER RELEASE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; SOLEUS MUSCLE; SPASTICITY; SPINAL CORD NERVE CELL;

ADMINISTRATION, ORAL; ADULT; BACLOFEN; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; FEMALE; H-REFLEX; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURAL PATHWAYS; SPASM; SPINAL CORD;

EID: 0034255931     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-2457(00)00352-7     Document Type: Article

References (30)

1. Azouvi P., et al. Effect of intrathecal baclofen on the monosynaptic reflex in humans: evidence for a postsynaptic action. J Neurol Neurosurg Psychiatry. 56:(5):1993;515-519.
2. Barry S.R. Baclofen has a presynaptic action at the crayfish neuromuscular junction. Brain Res. 311:(1):1984;152-156.
3. Bowery N.G., Pratt G.D. GABAB receptors as targets for drug action. Arzneimittelforschung. 42:(2A):1992;215-223.
4. Burke D., et al. Monosynaptic and oligosynaptic contributions to human ankle jerk and H-reflex. J Neurophysiol. 52:(3):1984;435-448.
5. Crone C., Nielsen J. Methodological implications of the post-activation depression. Exp Brain Res. 78:1989;28-32.
6. Crone C., et al. Disynaptic reciprocal inhibition of ankle extensors in spastic patients. Brain. 117:1994;1161-1168.
7. Crone C., et al. Amplitude of the maximum motor response (Mmax) in human muscles typically decreases during the course of an experiment. Exp Brain Res. 124:(2):1999;265-270.
8. Dones I., et al. A neurophysiological method for the evaluation of motor performance in spastic walking patients. Acta Neurochir Suppl (Wien). 64:1995;26-29.
9. Fischer Y., Parnas I. Activation of GABAB receptors at individual release boutons of the crayfish opener neuromuscular junction produces presynaptic inhibition. J Neurophysiol. 75:(4):1996;1377-1385.
10. Gerilovsky L., et al. Peripheral effects on the amplitude of monopolar and bipolar H-reflex potentials from the soleus muscle. Exp Brain Res. 76:(1):1989;173-181.
11. Hoogstraten M.C., et al. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients. Acta Neurol Scand. 77:(3):1988;224-230.
12. Horowitz S.H., Krarup C. Conduction studies of the normal sural nerve. Muscle Nerve. 15:1992;374-383.
13. Hultborn H., et al. Assessing changes in presynaptic inhibition of I a fibres: a study in man and the cat. J Physiol (London). 389:1987;729-756.
14. Hultborn H., et al. On the mechanism of the post-activation depression of the H-reflex in human subjects. Exp Brain Res. 108:1996;450-462.
15. Jimenez I., et al. Differential effects of (-)-baclofen on Ia and descending monosynaptic EPSPs. Exp Brain Res. 85:(1):1991;103-113.
16. Lev-Tov A., Pinco M. In vitro studies of prolonged synaptic depression in the neonatal rat spinal cord. J Physiol (London). 447:1992;149-169.
17. Macdonell R.A., et al. Intrathecal baclofen and the H-reflex. J Neurol Neurosurg Psychiatry. 52:(9):1989;1110-1112.
18. Milanov I.G. Mechanisms of baclofen action on spasticity. Acta Neurol Scand. 85:(5):1992;305-310.
19. Misgeld U., et al. A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol. 46:(4):1995;423-462.
20. Morita H., et al. Sensitivity of H-reflexes and stretch reflexes to presynaptic inhibition in humans. J Neurophysiol. 80:(2):1998;610-620.
21. Nielsen J., Hultborn H. Regulated properties of motoneurons and primary afferents: new aspects on possible spinal mechanisms underlying spasticity. Thilmann A.F. Spasticity: mechanism and management. 1993;177-191 Springer, Berlin.
22. Nielsen J., Petersen N. Is presynaptic inhibition distributed to corticospinal fibres in man? J Physiol (London). 477:(1):1994;47-58.
23. Nielsen J., et al. H-reflexes are less depressed following muscle stretch in spastic spinal cord injured patients than in healthy subjects. Exp Brain Res. 97:1993;173-176.
24. Nielsen J., et al. Changes in transmission across synapses of peripheral afferents in spastic multiple sclerosis patients. Brain. 118:1995;995-1004.
25. Pierrot-Deseilligny E. Electrophysiological assessment of the spinal mechanisms underlying spasticity. Electroenceph clin Neurophysiol Suppl. 41:1990;264-273.
26. Poser C.M., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 13:(3):1983;227-231.
27. Shefner J.M., et al. Peripheral sensory abnormalities in patients with multiple sclerosis. Muscle Nerve. 15:1992;73-76.
28. Stuart G.J., Redman S.J. The role of GABAA and GABAB receptors in presynaptic inhibition of Ia EPSPs in cat spinal motoneurones. J Physiol (London). 447:1992;675-692.
29. Tillakaratne N.J., et al. Gamma-aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues. Comp Biochem Physiol A Physiol. 112:(2):1995;247-263.
30. Ziemann U., et al. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 40:(3):1996;367-378.